Drug Database
EX

exenatide (exenatide LAR / AC 2993 LAR / Bydureon Pen)

✓ Approved

3SBio · GLP1R · 小分子

什么是 exenatide?

exenatide 是一种小分子,由3SBio研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intradermal Injection、Subcutaneous Injection。

药物档案

商品名exenatide LAR, AC 2993 LAR, Bydureon Pen
公司3SBio
药物类别小分子, 多肽类
分子靶点GLP1R
给药途径Injectable (Others), Intradermal Injection, Subcutaneous Injection
状态Approved

作用机制

分子靶点

exenatide 作用于 1 个分子靶点:

GLP1Rglucagon like peptide 1 receptor (GLP-1R, GLP-1-R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

exenatide 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersType 2 diabetes mellitus✓ Approved

相关研究文献

PubMedVeterinary medicine and science2026-11-19

Early Changes in Serum Protein Electrophoresis and Gamma Globulin during Initial 4 Weeks of Remdesivir Therapy in FIP Cats.

Khalili Kosar K, Cheraghi Hadi H, Saljooghian Isfahani Mohammad Hossein MH

Feline infectious peritonitis (FIP) is a fatal multisystem inflammatory disorder of cats that was historically considered untreatable before the emergence of direct-acting antivirals. The objective of the study was to evaluate early serial changes in serum protein electrophoresis (SPE) patterns in cats treated with remdesivir for FIP, emphasizing gamma-globulin concentrations and percentages. Animals included eighteen client-owned cats diagnosed with FIP based on clinical presentation, standard clinicopathological profiles, and confirmatory RT-PCR. Cats received remdesivir for 4 weeks and were monitored weekly through clinical examinations and laboratory evaluations. Blood samples were collected at baseline (prior to treatment initiation) and weekly for 4 weeks. The SPE analyzed the blood taken every week for the serum protein fractions, such as albumin and the different globulins, namely α1-, α2-, β1-, β2-, and γ-globulins. The albumin to globulin ratio (A/G ratio) was also determined. Gamma globulins were found to be significantly reduced from a median of 3.1 g/dL at week 2 to a median of 2.2 g/dL at the end of week 4 (p < .05) in cats that showed clinical response. Notably, ROC curve analysis identified that a gamma-globulin percentage <23% at week 4 and 18.96% by week 6 (AUC = 0.9105) was strongly associated with complete clinical recovery and sustained relapse-free remission. Serial monitoring of serum protein electrophoresis, particularly longitudinal trends in gamma-globulin percentages and the A/G ratio, provides an objective, practical biomarker strategy to evaluate treatment response and guide the safe timing of antiviral therapy cessation in cats with FIP.

PMID 43052221
阅读全文 →
PubMedThe Journal of animal ecology2026-11-19

From stable high costs to variable low costs: A continuum of non-breeding energy expenditure strategies in North Atlantic seabirds.

Frankish Caitlin K CK, Buckingham Lila L, Bråthen Vegard Sandøy VS, Descamps Sébastien S et al.

In the wild, many animals track shifting resource availability, a capacity with profound implications for fitness and population viability. Mobile species capable of long-distance movement can access a variety of habitats when not breeding, driving individuals to employ distinct behavioural strategies as they move through environments with contrasting effects on energetic costs (e.g. locomotion or thermoregulation) or gains (e.g. food intake). How energy expenditure is managed during this period may influence the degree to which individuals must accommodate variable resource demand, while its accumulation over time may affect how easily individuals rebuild condition ahead of reproduction. Using light-level geolocation-immersion loggers, we modelled the coefficient of variation in weekly (WEECOV_NB; reflecting stable vs. variable energy expenditure) and total (TEENB) non-breeding season energy expenditure for 8 to 33 North Atlantic populations of six pelagic seabird species contrasting in movement ability and distribution. Within-species, we tested for population differences in WEECOV_NB and TEENB, and, within-individuals, a link between the two (i.e. whether periods of above-average weekly energy expenditure, WEE, accumulate over time or are offset by periods of below-average WEE, leading to lower TEENB). Between-population differences in WEECOV_NB and TEENB were strongest in diving species with high flight costs, where both metrics increased with decreasing individual encountered sea surface temperature (a driver of thermoregulatory costs) and WEECOV_NB increased with individual migratory distance (two diving species only). We further identified a continuum of energy expenditure strategies, with individuals of all species except northern fulmars spanning low TEENB-high WEECOV_NB to high TEENB-low WEECOV_NB. This suggests that multiple energetic pathways for navigating the non-breeding season are possible in this marine region. Ultimately, these analyses underscore energetic trade-offs shaping non-breeding season movement strategies, with implications for energy demand and fitness. As energy expenditure must be matched by intake, non-breeding seabirds in the North Atlantic likely differ in the magnitude and timing of resource requirement. These populations may thus differ in their vulnerability to stressors that further elevate costs or reduce access to prey and in their capacity to cope with environmental change.

PMID 43053481
阅读全文 →
PubMedJournal of nephrology2026-11-19

Movement-related fear in home peritoneal dialysis: a cross-sectional study.

Qiao Aimin A, Wang Yan Y, Zhang Yuanyuan Y, Chen Guanglei G et al.

Movement-related fear may affect exercise engagement in patients receiving home peritoneal dialysis, but its psychological and clinical correlates remain unclear. We examined fear-related beliefs and associated factors in this population. This cross-sectional study included 223 patients at two hospitals in China. Movement-related fear was assessed using a 17-item questionnaire adapted from the Tampa Scale for Kinesiophobia. Anxiety symptoms, frailty, and exercise self-efficacy were assessed using established scales. The continuous fear-related belief score was the primary outcome; a score of at least 37 was used only for descriptive comparisons and sensitivity analyses. The mean score was 42.41 ± 5.94; 187 participants (83.9%) scored at least 37. In multivariable linear regression, anxiety symptoms (coefficient 2.884, P < 0.001) and frailty (coefficient 1.765, P = 0.033) were associated with higher scores. History of falls and greater complication burden were additional correlates in the primary model but were less consistent across sensitivity analyses. Fear-related belief scores showed a weak inverse correlation with self-reported weekly exercise frequency (Spearman correlation -0.178, P = 0.008). Anxiety symptoms and frailty were the principal clinical correlates of movement-related fear beliefs in patients receiving home peritoneal dialysis. These findings suggest that integrating psychological screening and frailty assessment into routine care may help identify individuals needing tailored exercise guidance and progressive activity support.

PMID 43053679
阅读全文 →
PubMedNature communications2026-11-19

Metabolic engineering and deep learning-driven protein engineering for N-Acetylneuraminic acid biosynthesis in Escherichia coli.

Wang Nan-Kai NK, Yue Song S, Chen Jin-Ping JP, Su Chang C et al.

N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway's catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L-1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km-1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L-1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L-1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production.

PMID 43052267
阅读全文 →
PubMedNaunyn-Schmiedeberg's archives of pharmacology2026-11-19

Protective effects of intermittent fasting and vitamin E against hyperthyroidism-associated ocular complications in Wistar rats.

Kumar Nirdesh N, Kumari Nidhi N, Singh Geeta G, Singh Beyant B et al.

Our study endeavours to prevent hyperthyroidism-associated ocular complications through the synergy of intermittent fasting and vitamin E supplementation. Our aim was to reduce the incidence of hyperthyroidism-associated ocular complications by combining these two interventions, while carefully monitoring dietary intake and supplementing with vitamin E. In this experiment, animals were divided into normal, hyperthyroidism control, dual, vitamin E, and intermittent fasting groups. Hyperthyroidism was induced by administering thyroxine for 24 days. Animals in the treatment groups took vitamin E and practised intermittent fasting. Intraocular pressure was measured weekly during the protocol. After the protocol, antioxidant status, malondialdehyde and nitrite level, protein content, retinal pictures, histopathology of lens and thyroid profile were analysed. Rats with hyperthyroidism control exhibited elevated (p < 0.001) intraocular pressure, lipid peroxidation, total protein content, and thyroid hormone levels, while antioxidant and nitrite levels decreased (p < 0.001). However, our non-drug therapy significantly (p < 0.001) improved all of these parameters, bringing them to their optimum levels. Intermittent fasting prevented ocular disease caused by hyperthyroidism by reducing oxidative stress and fibro genic matter deposition, and modulating nitrite balance. It works best when combined with vitamin E for superior antioxidant benefits. Our proposed remedies not only improved ocular function but also provided physiological benefits, suggesting a link to metabolic, ophthalmic, and neurogenic diseases in future projections.

PMID 43052389
阅读全文 →
PubMedClinical transplantation2026-11-19

Innovations in Psychosocial Care Management for Acute Alcohol-Related Hepatitis Transplant Recipients: Feasibility and Acceptability of a Motivational Interviewing Video Reinforcement Intervention.

DiMartini Andrea F AF, Amrhein Paul C PC, Lee Mary M, Behari Jaideep J et al.

Acute Alcohol-related hepatitis (AAH) liver transplant (LT) recipients are often transplanted urgently prior to addiction counseling. Interventions to promote maintenance of abstinence are needed for this population. We developed and piloted the feasibility and acceptability of an innovative intervention for AAH patients; a motivational interviewing (MI) video reinforcement intervention to strengthen motivation for abstinence and paired it with a transdermal alcohol monitoring biosensor (TAS). MI is an established technique for eliciting reasons to stop drinking (i.e., change talk). Ten AAH LT recipients participated in a 4-month pilot of our video intervention. Participants underwent a video-taped MI interview from which selected clips were archived on an iPad as a personalized video library of their change talk. They viewed videos weekly, wore the TAS, and were queried about alcohol use with a standardized instrument. At intake participants expressed poor efforts to change behavior but felt confident of not drinking. At study end qualitative data showed participants felt repeated video viewing strengthened motivation by reminding them of their reasons to stay sober keeping those reasons uppermost in their mind. They noted repeated viewing of their videos reinforced their intentions. However, some felt that seeing themselves was distracting or disturbing. Participants identified potential intervention format and delivery improvements. While the emotional intensity of their LT experience could be compelling, for some revisiting this time was distressing. Intervention refinements to further enhance acceptability and feasibility while minimizing distress are underway with plans for subsequent efficacy evaluation in a randomized controlled trial.

PMID 43052554
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多exenatide